Home › Trial NCT00992134
Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma
- Trial IDNCT00992134
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorSt. Bortolo Hospital
- Enrollment41
- Start date2009-06
- ConditionsLymphoma, Mantle-Cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.